{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:25:15Z","timestamp":1784913915252,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bbrc.2019.06.121","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:43:49Z","timestamp":1562028229000},"page":"983-990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["PLAC8 overexpression correlates with PD-L1 upregulation and acquired resistance to chemotherapies in gallbladder carcinoma"],"prefix":"10.1016","volume":"516","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-6770","authenticated-orcid":false,"given":"Ke","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Jun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Xiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ling","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hou-Bao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.06.121_bib1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1470-2045(14)70212-8","article-title":"Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial","volume":"15","author":"Malka","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2019.06.121_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/bjs.11035","article-title":"Systematic review of management of incidental gallbladder cancer after cholecystectomy","volume":"106","author":"Soreide","year":"2019","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.bbrc.2019.06.121_bib3","doi-asserted-by":"crossref","first-page":"12211","DOI":"10.3748\/wjg.v21.i43.12211","article-title":"Gallbladder carcinoma: prognostic factors and therapeutic options","volume":"21","author":"Goetze","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2019.06.121_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/cas.13438","article-title":"Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine","volume":"109","author":"Ikeda","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2019.06.121_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s13304-015-0328-x","article-title":"Surgical treatment of gallbladder carcinoma: a critical review","volume":"67","author":"Kakaei","year":"2015","journal-title":"Updates Surg"},{"key":"10.1016\/j.bbrc.2019.06.121_bib6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3892\/or.2012.2156","article-title":"Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation","volume":"29","author":"Wang","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2019.06.121_bib7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature02173","article-title":"An ABC transporter with a secondary-active multidrug translocator domain","volume":"426","author":"Venter","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2019.06.121_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/346362a0","article-title":"Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport","volume":"346","author":"Hyde","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2019.06.121_bib9","article-title":"Genomic ERBB2\/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis","volume":"68","author":"Li","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2019.06.121_bib10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/his.13669","article-title":"Clinical relevance of PD-L1 expression in gallbladder cancer: a potential target for therapy","volume":"73","author":"Neyaz","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.bbrc.2019.06.121_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jtho.2017.10.011","article-title":"Increased response rates to salvage chemotherapy administered after PD-1\/PD-L1 inhibitors in patients with non-small cell lung cancer","volume":"13","author":"Park","year":"2018","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.bbrc.2019.06.121_bib12","first-page":"545","article-title":"Novel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapies","volume":"4","author":"Simone","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.bbrc.2019.06.121_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/107327481402100112","article-title":"Update on immune checkpoint inhibitors in lung cancer","volume":"21","author":"Creelan","year":"2014","journal-title":"Cancer Control"},{"key":"10.1016\/j.bbrc.2019.06.121_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature13904","article-title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","volume":"515","author":"Powles","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2019.06.121_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2019.06.121_bib16","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2019.06.121_bib17","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1172\/JCI71103","article-title":"Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer","volume":"124","author":"Li","year":"2014","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2019.06.121_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41419-018-0580-3","article-title":"The novel KLF4\/PLAC8 signaling pathway regulates lung cancer growth","volume":"9","author":"Jia","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2019.06.121_bib19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.celrep.2014.03.061","article-title":"Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression","volume":"7","author":"Kinsey","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2019.06.121_bib20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1159\/000491976","article-title":"ONZIN upregulation by mutant p53 contributes to osteosarcoma metastasis through the CXCL5-MAPK signaling pathway","volume":"48","author":"Zhang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2019.06.121_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/0008-5472.CAN-15-0216","article-title":"PLAC8 localizes to the inner plasma membrane of pancreatic cancer cells and regulates cell growth and disease progression through critical cell-cycle regulatory pathways","volume":"76","author":"Kaistha","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2019.06.121_bib22","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.2337\/db14-1709","article-title":"Epigenetic regulation of placenta-specific 8 contributes to altered function of endothelial colony-forming cells exposed to intrauterine gestational diabetes mellitus","volume":"64","author":"Blue","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2019.06.121_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2017.02.024","article-title":"Identification and characterization of a novel multifunctional placenta specific protein 8 in Dugesia japonica","volume":"613","author":"Pang","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2019.06.121_bib24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s11255-017-1578-y","article-title":"Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma","volume":"49","author":"Shi","year":"2017","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.bbrc.2019.06.121_bib25","article-title":"Alterations in PD-L1 expression associated with acquisition of resistance to ALK inhibitors in ALK-rearranged lung cancer","author":"Kim","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.bbrc.2019.06.121_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2017.08.023","article-title":"Induction of Plac8 promotes pro-survival function of autophagy in cadmium-induced prostate carcinogenesis","volume":"408","author":"Kolluru","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2019.06.121_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/gutjnl-2016-312794","article-title":"Protein and glycomic plasma markers for early detection of adenoma and colon cancer","volume":"67","author":"Rho","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2019.06.121_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.eururo.2011.05.035","article-title":"Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours","volume":"60","author":"Fleischmann","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbrc.2019.06.121_bib29","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood-2013-06-508044","article-title":"Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells","volume":"122","author":"Greaves","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2019.06.121_bib30","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1038\/sj.onc.1208897","article-title":"Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway","volume":"24","author":"Rogulski","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2019.06.121_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/156800913804486584","article-title":"Apoptosis suppression by candidate oncogene PLAC8 is reversed in other cell types","volume":"13","author":"Mourtada-Maarabouni","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbrc.2019.06.121_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-019-0700-2","article-title":"WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer","volume":"38","author":"Castagnoli","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2019.06.121_bib33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature10755","article-title":"Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting","volume":"482","author":"Matsushita","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2019.06.121_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2018.05.052","article-title":"LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade","volume":"174","author":"Sheng","year":"2018","journal-title":"Cell"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19312598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19312598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T05:06:25Z","timestamp":1563512785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19312598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0006291X19312598"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.121","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLAC8 overexpression correlates with PD-L1 upregulation and acquired resistance to chemotherapies in gallbladder carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}